HR 6417
116th Congress
House
Health
Cell biology and embryology
Medical ethics
Medical research
Organ and tissue donation and transplantation
Research administration and funding
Protecting Cures Act of 2020
Introduced: March 31, 2020
Introduced by:
Schakowsky, Janice D.
Democratic
· Illinois
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 31, 2020
Referred to the House Committee on Energy and Commerce.
Mar 31, 2020
Introduced in House
Plain-English summary
Protecting Cures Act of 2020
This bill prohibits the Department of Health and Human Services from withholding funding, because of ethical considerations, for research activities that use human fetal tissue, provided that the research activities have been recommended for approval by an institutional review board and otherwise comply with existing laws concerning human fetal tissue. The bill also establishes that this research is not unethical by deeming the 1988 report of the Human Fetal Tissue Transplantation Research Panel as meeting relevant statutory requirements with respect to approving the ethical status of such research.
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1